Literature DB >> 31379008

Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada.

Andreas Pilarinos1,2, Brittany Barker1,3, Ekaterina Nosova1, M-J Milloy1,4, Kanna Hayashi1,5, Evan Wood1,4, Thomas Kerr1,4, Kora DeBeck1,6.   

Abstract

BACKGROUND AND AIMS: Many people who use drugs (PWUD) are coerced into receiving treatment. This study aimed to assess changes in substance use and related outcomes before versus after treatment in people coerced into treatment, voluntarily attending treatment or not attending treatment.
DESIGN: Data from three linked prospective cohort studies of PWUD were used. McNemar's test and non-linear growth curve modeling were employed to: (a) assess changes in substance use patterns before and after coerced addiction treatment and (b) compare these changes with changes in PWUD who (1) voluntarily accessed and (2) did not access treatment.
SETTING: Vancouver, Canada. PARTICIPANTS: A total of 3196 community-recruited PWUD. MEASUREMENTS: The outcome variables were substance use and related outcomes assessed by self-reported questionnaire. The input variable was self-reported coerced addiction treatment (defined as being forced into addiction treatment by a doctor or the criminal justice system), voluntary treatment versus no treatment.
FINDINGS: Between September 2005 and June 2015, 399 (12.5%) participants reported being coerced into addiction treatment. In McNemar's test, there were no statistically significant reductions in within-group substance use outcomes for people coerced into treatment, voluntarily attending treatment or not attending treatment. In non-linear growth curve analyses, there were no statistically significant differences in the before and after substance use patterns between those coerced into treatment versus either of the two control groups (all P > 0.05). In subanalyses, we found no statistically significant differences in substance use patterns between people who reported formal coerced treatment through the criminal justice system and people who reported informal coerced treatment through a physician.
CONCLUSIONS: Among PWUD in Vancouver, Canada, there appear to be no statistically significant improvements in substance use outcomes among those reporting coerced addiction treatment, those voluntarily accessing treatment, and those not attending treatment.
© 2019 Society for the Study of Addiction.

Entities:  

Keywords:  Addiction treatment; before and after analysis; coerced treatment; compulsory treatment; longitudinal study; substance use disorders

Year:  2019        PMID: 31379008      PMCID: PMC6933075          DOI: 10.1111/add.14769

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  61 in total

1.  Substance use disorder patients who are mandated to treatment: characteristics, treatment process, and 1- and 5-year outcomes.

Authors:  John F Kelly; John W Finney; Rudolf Moos
Journal:  J Subst Abuse Treat       Date:  2005-04

2.  Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users.

Authors:  Evan Wood; Kathy Li; Anita Palepu; David C Marsh; Martin T Schechter; Robert S Hogg; Julio S G Montaner; Thomas Kerr
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

3.  Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies.

Authors:  Cari L Miller; Thomas Kerr; James C Frankish; Patricia M Spittal; Kathy Li; Martin T Schechter; Evan Wood
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

4.  Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Ruth Zhang; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  J Public Health (Oxf)       Date:  2009-09-23       Impact factor: 2.341

5.  Psychotherapy for opiate addicts. Does it help?

Authors:  G E Woody; L Luborsky; A T McLellan; C P O'Brien; A T Beck; J Blaine; I Herman; A Hole
Journal:  Arch Gen Psychiatry       Date:  1983-06

6.  Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users.

Authors:  D Vlahov; M Safaien; S Lai; S A Strathdee; L Johnson; T Sterling; D D Celentano
Journal:  AIDS       Date:  2001-11-23       Impact factor: 4.177

7.  Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.

Authors:  Jessica M Peirce; Nancy M Petry; Maxine L Stitzer; Jack Blaine; Scott Kellogg; Frank Satterfield; Marion Schwartz; Joe Krasnansky; Eileen Pencer; Lolita Silva-Vazquez; Kimberly C Kirby; Charlotte Royer-Malvestuto; John M Roll; Allan Cohen; Marc L Copersino; Ken Kolodner; Rui Li
Journal:  Arch Gen Psychiatry       Date:  2006-02

8.  Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study.

Authors:  Evan Wood; Jo-Anne Stoltz; Julio S G Montaner; Thomas Kerr
Journal:  Harm Reduct J       Date:  2006-05-24

9.  Improved drug-use patterns at 6 months post-discharge from inpatient substance use disorder treatment: results from compulsorily and voluntarily admitted patients.

Authors:  Adrian R Pasareanu; John-Kåre Vederhus; Anne Opsal; Øistein Kristensen; Thomas Clausen
Journal:  BMC Health Serv Res       Date:  2016-07-20       Impact factor: 2.655

10.  Inability to access addiction treatment predicts injection initiation among street-involved youth in a Canadian setting.

Authors:  Kora DeBeck; Thomas Kerr; Seonaid Nolan; Huiru Dong; Julio Montaner; Evan Wood
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-01-06
View more
  1 in total

1.  The effect of cannabis policies on treatment outcomes for cannabis use among U.S. adults.

Authors:  Jessica L Bourdon; Meredith W Francis; Lena Jia; Chenxue Liang; Helen I Robinson; Richard A Grucza
Journal:  J Subst Abuse Treat       Date:  2021-06-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.